BioNexus Gene Lab (BGLC) Competitors $2.73 +0.06 (+2.25%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$2.70 -0.03 (-1.25%) As of 04/17/2025 05:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BGLC vs. BRTX, MRAI, KDLY, MGRX, OTRK, SSY, ATPC, ACON, ATIP, and VSEEShould you be buying BioNexus Gene Lab stock or one of its competitors? The main competitors of BioNexus Gene Lab include BioRestorative Therapies (BRTX), Marpai (MRAI), Kindly MD (KDLY), Mangoceuticals (MGRX), Ontrak (OTRK), SunLink Health Systems (SSY), Agape ATP (ATPC), Aclarion (ACON), ATI Physical Therapy (ATIP), and Vsee Health (VSEE). These companies are all part of the "healthcare" industry. BioNexus Gene Lab vs. BioRestorative Therapies Marpai Kindly MD Mangoceuticals Ontrak SunLink Health Systems Agape ATP Aclarion ATI Physical Therapy Vsee Health BioNexus Gene Lab (NASDAQ:BGLC) and BioRestorative Therapies (NASDAQ:BRTX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, community ranking, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations. Which has more risk and volatility, BGLC or BRTX? BioNexus Gene Lab has a beta of 5.41, indicating that its stock price is 441% more volatile than the S&P 500. Comparatively, BioRestorative Therapies has a beta of 68.9, indicating that its stock price is 6,790% more volatile than the S&P 500. Does the MarketBeat Community believe in BGLC or BRTX? BioRestorative Therapies received 2 more outperform votes than BioNexus Gene Lab when rated by MarketBeat users. CompanyUnderperformOutperformBioNexus Gene LabN/AN/ABioRestorative TherapiesOutperform Votes2100.00% Underperform VotesNo Votes Does the media refer more to BGLC or BRTX? In the previous week, BioNexus Gene Lab and BioNexus Gene Lab both had 3 articles in the media. BioRestorative Therapies' average media sentiment score of 0.80 beat BioNexus Gene Lab's score of 0.57 indicating that BioRestorative Therapies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioNexus Gene Lab 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioRestorative Therapies 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of BGLC or BRTX? 18.9% of BioNexus Gene Lab shares are held by institutional investors. Comparatively, 69.4% of BioRestorative Therapies shares are held by institutional investors. 0.7% of BioNexus Gene Lab shares are held by insiders. Comparatively, 25.5% of BioRestorative Therapies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts rate BGLC or BRTX? BioRestorative Therapies has a consensus target price of $18.00, indicating a potential upside of 928.57%. Given BioRestorative Therapies' stronger consensus rating and higher possible upside, analysts plainly believe BioRestorative Therapies is more favorable than BioNexus Gene Lab.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioNexus Gene Lab 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00BioRestorative Therapies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable valuation and earnings, BGLC or BRTX? BioNexus Gene Lab has higher revenue and earnings than BioRestorative Therapies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioNexus Gene Lab$9.26M0.53-$2.63MN/AN/ABioRestorative Therapies$401K32.75-$14.41M-$1.16-1.51 Is BGLC or BRTX more profitable? BioNexus Gene Lab has a net margin of -10.17% compared to BioRestorative Therapies' net margin of -2,697.08%. BioNexus Gene Lab's return on equity of -9.93% beat BioRestorative Therapies' return on equity.Company Net Margins Return on Equity Return on Assets BioNexus Gene Lab-10.17% -9.93% -8.43% BioRestorative Therapies -2,697.08%-98.49%-75.23% SummaryBioRestorative Therapies beats BioNexus Gene Lab on 9 of the 14 factors compared between the two stocks. Get BioNexus Gene Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for BGLC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGLC vs. The Competition Export to ExcelMetricBioNexus Gene LabMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.91M$2.78B$5.30B$7.34BDividend YieldN/A31.35%5.45%4.30%P/E RatioN/A14.4621.8617.80Price / Sales0.53192.58380.6797.70Price / CashN/A57.5638.2634.64Price / Book4.964.486.453.98Net Income-$2.63M-$22.21M$3.22B$247.81M1 Month Performance-11.65%-8.37%-9.74%-7.85%1 Year Performance-54.48%7.26%11.49%1.59% BioNexus Gene Lab Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGLCBioNexus Gene Lab0.6175 of 5 stars$2.73+2.2%N/A-67.8%$4.91M$9.26M0.0030Short Interest ↓Gap DownBRTXBioRestorative Therapies3.5811 of 5 stars$1.78-0.6%$18.00+911.2%+21.5%$13.36M$401,000.00-1.167Short Interest ↓MRAIMarpaiN/A$1.00+19.0%N/A-57.7%$12.51M$34.87M-0.38150Gap UpKDLYKindly MD0.1603 of 5 stars$1.66-3.5%N/AN/A$10.37M$2.72M-2.52N/ANews CoverageGap UpMGRXMangoceuticals0.413 of 5 stars$1.82+16.3%N/A-96.2%$9.41M$615,873.00-0.313Short Interest ↑OTRKOntrak2.8101 of 5 stars$1.66+5.8%$45.00+2,610.8%-65.8%$7.00M$11.24M-0.16250Earnings ReportShort Interest ↓Gap UpSSYSunLink Health SystemsN/A$0.85-4.7%N/A+36.0%$5.97M$31.23M6.061,376Analyst ForecastGap UpATPCAgape ATP0.8321 of 5 stars$1.42+7.6%N/A-61.0%$5.67M$1.32M-1.9540Gap UpACONAclarion2.3294 of 5 stars$10.00+20.0%$11,758.50+117,485.0%-99.7%$5.07M$49,289.000.007High Trading VolumeATIPATI Physical TherapyN/A$1.00-1.0%N/A-78.0%$4.46M$741.86M-0.055,600VSEEVsee Health1.6334 of 5 stars$1.07+2.3%$5.00+367.3%N/A$3.86M$6.38M0.00N/ANews Coverage Related Companies and Tools Related Companies BRTX Alternatives MRAI Alternatives KDLY Alternatives MGRX Alternatives OTRK Alternatives SSY Alternatives ATPC Alternatives ACON Alternatives ATIP Alternatives VSEE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGLC) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNexus Gene Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
